Send to

Choose Destination
J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1396-402. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.021. Epub 2014 Apr 26.

Activation of peroxisome proliferator-activated receptor β/δ attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats.

Author information

Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China; Department of Neurosurgery, Urumqi General Hospital of PLA, Urumqi, China.
Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Department of Cardiology, The First Hospital of PLA, Lanzhou, China.
Department of Neurosurgery, Xijing Institute of Clinical Neuroscience, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Department of Neurosurgery, People's Hospital of Jishan County, Shanxi, China.
Department of Neurosurgery, Xinjiang Corps Hospital, Urumqi, China.
Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China. Electronic address:



Peroxisome proliferator-activated receptor (PPAR)-β/δ is a transcription factor that belongs to the nuclear hormone receptor family. There is little information about the effects of the immediate administration of specific ligands of PPAR-β/δ (GW0742) in animal models of acute ischemic stroke. Using a rat model of middle cerebral ischemia occlusion (MCAO) in vivo, we have investigated the effect of pretreatment with GW0742 before MCAO.


The neuroprotective effect of GW0742 against acute ischemic stroke was evaluated by the neurologic deficit score (NDS), dry-wet weight, and 2,3,5-triphenyltetrazolium chloride staining. The levels of interleukin (IL)-1β, nuclear factor (NF)-κB, and tumor necrosis factor (TNF)-α were detected by an enzyme-linked immunosorbent assay. The expressions of inducible nitric oxide synthase (iNOS), Bax, and Bcl-2 were detected by Western blot. The apoptotic cells were counted by in situ terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling assay.


The pretreatment with GW0742 significantly increased the expression of Bcl-2, and significantly decreased in the volume of infarction, NDS, edema, expressions of IL-1β, NF-κB, TNFα, and Bax, contents of iNOS and the apoptotic cells in infarct cerebral hemisphere compared with rats in the vehicle group at 24 hours after MCAO.


The study suggests the neuroprotective effect of the PPAR-β/δ ligand GW0742 in acute ischemic stroke by a mechanism that may involve its anti-inflammatory and antiapoptotic action.


GW0742; PPAR-β/δ; anti-inflammatory; middle cerebral artery occlusion (MCAO); rat

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center